Printed From BioPortfolio.com

FDA Approves Drug to Help Curb a Tough-to-Treat Prostate Cancer

11:00 EST 14 Feb 2018 | Drugs.com

WEDNESDAY, Feb. 14, 2018 -- A new drug that can stall the progression of a particularly hard-to-treat form of prostate cancer has been approved for use by U.S. health officials. In a recent study, the drug called Erleada (apalutamide) has shown...

Original Article: FDA Approves Drug to Help Curb a Tough-to-Treat Prostate Cancer

More From BioPortfolio on "FDA Approves Drug to Help Curb a Tough-to-Treat Prostate Cancer"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches